🔗 Share this article

An underground economy for unlicensed weight-loss drugs is being driven by social media fitness personalities and sellers on messaging platforms, based on recent findings.

Investigational Treatment Gaining Traction Online

Retatrutide, which remains in research studies, is being advertised by online personalities for its alleged weight-reducing properties. Followers are encouraged to message these profiles directly for supplier links, while also obtaining promotional offers.

Active Commerce on Messaging Platforms

Separately, a flourishing market exists on Telegram, where groups with thousands of members share “before and after” images, injection guides and claims of next-day UK delivery. Vendors promote the drug there before directing buyers to WhatsApp for transactions.

Understanding The Experimental Drug

This medication is an experimental injection created by US drugmaker Eli Lilly. The drug affects three gut hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Preliminary studies indicate it could assist individuals lose up to 25% of their body weight. Nicknamed the “triple G”, the drug is being hailed online as the next Ozempic.

Medical Experts Voice Worries

Nevertheless, physicians and pharmacists have warned that the distribution of what is still an unlicensed drug in the UK is a cause for concern and could lead to users administering products of unknown origin.

Some experts stated the popularity for the experimental drug could be connected to the increasing cost of licensed weight loss products such as Mounjaro.

Regulatory Status and Enforcement

Marketing retatrutide on social media or Telegram is prohibited in the UK, as it is an unapproved drug that cannot be promoted or supplied for human use under the Human Medicines Regulations 2012.

Some influencers attempt to circumvent the regulations by referring to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled drug, but promotion and supply can still breach medicines, advertising, and consumer laws, potentially leading to fines, prosecution or prison.

Platform Response and Material Elimination

According to TikTok, the service has taken down violative material and banned related keywords and query recommendations. The company stated it was dedicated to keeping the service safe and allocating resources in enhancing compliance measures.

Digital Marketplace Activities

Research also discovered communities with up to nine thousand participants selling retatrutide using the platform's integrated discovery tool, which functions like a public directory. Entering “retatrutide” immediately displays channels with thousands of members, populated with photos of weight loss, glowing testimonials and step-by-step instructions for mixing or injecting at home.

Within minutes of joining one community, a seller shared contact information, where most transactions take place. The seller provided an guidebook and guaranteed shipping within 48 hours. When asked whether the product was genuine, one seller responded: “You can’t be sure.” Another provided a photo of a supposed testing documentation. None asked about body mass, health issues or previous experience.

Product Information and Costs

Inside these communities, posts display dark colored packages with Royal Mail labels, claiming to contain fresh supplies. One communication stated: “It took eight of us to load them this morning.”

Customers can select between powder vials, mixed at residence with sterile water, or pre-filled pens typically priced at 160 pounds for 20 milligrams. When questioned how long a pen should last, vendors give conflicting answers varying between a several days to “depends on your body”.

Service Moderation and Security Measures

A spokesperson for the messaging service said it actively monitored harmful content on its platform including content that encouraged the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.

Healthcare Professional Cautions

“People are administering materials they cannot confirm. Although the science behind retatrutide is sound, these online products may not include what they advertise,” said Jason Murphy, the head of pharmaceutical services at a pharmacy service.

A medical professional of Asda Online Doctor linked the increase in interest to current price rises for authorized weight-loss medications such as Mounjaro. “With prices rising, patients are using social media. But counterfeit treatments are highly risky. You cannot know what’s inside or whether the environment they were produced in was clean,” she said.

Her staff has already seen patients injured by personal administration from unverified sources. “We recognize the disappointment, but purchasing from Telegram or WhatsApp is taking chances with your health,” stated Wyllie. “These substances could be contaminated or improperly measured.”

Manufacturer Position

A representative from the pharmaceutical company stated retatrutide was in phase 3 research studies and had not been reviewed or approved by any government authority anywhere in the world. “Consequently at this point no one can sell [it] for personal consumption,” they said, noting that any item “falsely representing itself as a company experimental substance not yet approved … may expose patients to possibly serious health risks”.